Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1
Jun-Xian Du, Yihong Luo, Sijia Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Alternative splicing and related RNA binding proteins in human health and disease
Yining Tao, Qi Zhang, Haoyu Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 71
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
Xuemei Lv, Xiaoyu Sun, Yang Gao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Ultrasound Responsive Nanovaccine Armed with Engineered Cancer Cell Membrane and RNA to Prevent Foreseeable Metastasis
Wenqi Sun, Panpan Ji, Tianhua Zhou, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 21
Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis
Wenjuan Li, Ying Huang, Yi-an Lin, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113385-113385
Open Access | Times Cited: 16
Ferroptosis and circular RNAs: new horizons in cancer therapy.
Asif Ahmad Bhat, Neelima Kukreti, Muhammad Afzal, et al.
PubMed (2024) Vol. 23, pp. 570-599
Closed Access | Times Cited: 7
Autophagy regulation by RNA alternative splicing and implications in human diseases
Patricia González-Rodríguez, Daniel J. Klionsky, Bertrand Joseph
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis
Xiang Song, Xinzhao Wang, Xiqi Chen, et al.
Journal of Proteomics (2023) Vol. 292, pp. 105055-105055
Closed Access | Times Cited: 14
YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance
Zihan Geng, Jun-Xian Du, Yue-Da Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Cyperotundone promotes chemosensitivity of breast cancer via SRSF1
Chao Li, Lin Wang, Zhaoyun Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Therapeutic Targeting of RNA Splicing in Cancer
Elizabeth A. Bonner, Stanley Chun-Wei Lee
Genes (2023) Vol. 14, Iss. 7, pp. 1378-1378
Open Access | Times Cited: 12
HIV-1 Vpr induces ciTRAN to prevent transcriptional repression of the provirus
Vipin Bhardwaj, Aman Singh, Aditi Choudhary, et al.
Science Advances (2023) Vol. 9, Iss. 36
Open Access | Times Cited: 12
Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms
Ming Zhang, Can Chen, Zequn Lu, et al.
Gastroenterology (2023) Vol. 165, Iss. 5, pp. 1151-1167
Closed Access | Times Cited: 11
Development and validation of AI/ML derived splice-switching oligonucleotides
Alyssa D Fronk, Miguel Manzanares, Paulina Zheng, et al.
Molecular Systems Biology (2024) Vol. 20, Iss. 6, pp. 676-701
Open Access | Times Cited: 4
Overview of splicing variation in ovarian cancer
Min Zhou, Mingyao Tian, Zhuoer Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189288-189288
Closed Access
Tumor-promoting effect and tumor immunity of SRSFs
Shuai Zhang, Yongxi Zhang, Sijia Feng, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
The Development of Selective Chemical Probes for Serine Arginine Protein Kinase 3
Danielle Hanke, Conall McCutcheon, Brent D. G. Page
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 4
Open Access
Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis
Miaomiao Li, Yi Wang, Xinyan Li, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway
Zhigang Feng, Shanjia Ke, Chaoqun Wang, et al.
Oncogene (2023) Vol. 42, Iss. 24, pp. 2017-2030
Open Access | Times Cited: 10
SRSF1 Is Required for Mitochondrial Homeostasis and Thermogenic Function in Brown Adipocytes Through its Control of Ndufs3 Splicing
Ningyang Yuan, Lei Shen, Qian Peng, et al.
Advanced Science (2024) Vol. 11, Iss. 21
Open Access | Times Cited: 3
High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms
Shuqi Li, Xinyi Huang, Shuang Zheng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Targeting Splicing Factor SRSF6 for Cancer Therapy
Wenting She, Jun Shao, Rong Jia
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 22
DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective
Massimiliano Secchi, Camilla Lodola, Anna Garbelli, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3820-3820
Open Access | Times Cited: 15
Splicing factor SRSF1 is essential for homing of precursor spermatogonial stem cells in mice
Longjie Sun, Zheng Lv, Xuexue Chen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 7
Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients
Jinrong He, Dan Li, Qun-Xian Zhang, et al.
Aging (2023) Vol. 15, Iss. 22, pp. 13265-13286
Open Access | Times Cited: 7
High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
Guoshun Zhang, Bin Liu, Hua Shang, et al.
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top